The largest database of trusted experimental protocols

Ez cytox cell viability kit

Manufactured by DoGenBio
Sourced in United States

The EZ-cytox cell viability kits are a set of laboratory tools designed to assess the metabolic activity and viability of cells in culture. The kits provide a colorimetric or fluorometric readout that indicates the number of living cells present in a sample.

Automatically generated - may contain errors

7 protocols using ez cytox cell viability kit

1

Pneumococcal Toxicity and ASD Impact

Check if the same lab product or an alternative is used in the 5 most similar protocols
The toxicity of S. pneumoniae in the presence or absence of ASD was detected by evaluating HMEEC viability upon treatment with S. pneumoniae or ASD, or co-treatment with both. HMEECs were kindly provided by Dr. Lim (House Ear Institutes, Los Angeles, CA, United States) (Chun et al., 2002 (link)). HMEECs were cultured (1 × 104) in a 96-well plate in airway epithelial cell growth medium (PromoCell GmbH, Sickingenstr Heidelberg Germany) supplemented with bovine pituitary extract (0.004 ml/ml), epidermal growth factor (10 ng/ml), insulin (5 μg/ml), hydrocortisone (0.5 μg/ml), epinephrine (0.5 μg/ml), triiodo-L-thyronine (6.7 ng/ml), transferrin (10 μg/ml), retinoic acid (0.1 ng/ml), and 1% fetal bovine serum for 24 h at 37°C in 5% CO2. Then, cells were exposed to ASD (300 μg/ml) in serum-free medium for 8 h, followed by S. pneumoniae treatment (MOI 10) for 15 h. The viability of HMEECs was determined by using EZ-cytox cell viability kit (Dogenbio, South Korea) as per the manufacturer’s instruction, and absorbance was measured at 450 nm.
+ Open protocol
+ Expand
2

Pneumococcal Infection in Airway Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HMEECs were maintained and routinely cultured in airway epithelial cell growth medium (PromoCell GmbH, Sickingenstr Heidelberg, Germany) supplemented with bovine pituitary extract (0.004 mL/mL), epidermal growth factor (10 ng/mL), insulin (5 µg/mL), hydrocortisone (0.5 µg/mL), epinephrine (0.5 µg/mL), triiodo-L-thyronine (6.7 ng/mL), transferrin (10 µg/mL), retinoic Acid (0.1 ng/mL) and 1% fetal bovine serum and 5% CO2. In a 96-well plate, 1 × 104 HMEECs were seeded and incubated at 37 °C with 5% CO2 for 24 hr. Following incubation, cells were washed with PBS and medium was replaced with UP (200 µg/mL) containing medium (antibiotic free medium) and further incubated for 8 hr. The HMEECs pre-exposed to UP were infected with S. pneumoniae (MOI 10) for 15 hr. The HMEECs viability was detected using the EZ-cytox cell viability kit (Dogenbio, Korea) as per manufacturer’s instruction.
+ Open protocol
+ Expand
3

Silica-based Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The silica powder and plate were obtained from Merck (Darmstadt, Germany). The Sephadex LH-20 resin was purchased from Sigma-Aldrich (St. Louis, MO, USA). The EZ-Cytox cell viability kit was obtained from DoGenBio (Seoul, Korea). The other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
4

Cell Viability Assay using EZ-cytox Kit

Check if the same lab product or an alternative is used in the 5 most similar protocols
EZ-cytox cell viability kits (DoGenBio Co., Ltd., Seoul, Korea) was used according to the manufacturer’s instructions. Briefly, cells (1 × 104 cells/well) were plated in 96-well plates and incubated for 24, 48, or 72 h. After incubation, EZ-cytox was added to each well and incubated for 2 h. Then, the absorbance was recorded on a microplate reader (Synergy H1; BioTek, Winooski, VT, USA) at 490 nm.
+ Open protocol
+ Expand
5

Cisplatin Cytotoxicity Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitory concentrations (ICs) were determined using EZ-cytox cell viability kits (#EZ-1000, DLS-1906, DoGenBio Co., Ltd., Seoul, Korea). The cells (1 × 104 cells/well) were plated in 96-well plates and incubated for 24 h (h). The cells were treated with different concentration of cisplatin (0–100 µM) for parental and cisplatin (0–400 µM) for resistant cell lines. After incubation for 24, 48 and 72 h, EZ-cytox solution was added to each well and incubated for 2 h. Absorbance was then recorded on a microplate reader (Synergy H1; BioTek Instruments, Inc., Winooski, VT, USA) at the wavelength of 490 nm. The IC50 values were analyzed using GraphPad Prism software (version 5.0, GraphPad Software Inc., San Diego, CA, USA).
+ Open protocol
+ Expand
6

Cell Viability and IC50 Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability and IC50 were determined using EZ-cytox cell viability kits (#EZ-1000, DLS-1906, DoGenBio Co., Ltd., Seoul, Korea). The cells (1 × 104 cells/well) were plated in 96-well plates and incubated for desired period of time. The cells were treated with different concentration of drugs. After incubation, EZ-cytox solution was added to each well and incubated for 2 h. Absorbance was then recorded on a microplate reader (Synergy H1; BioTek Instruments, Inc., Winooski, VT, USA) at the wavelength of 490 nm. The IC50 values were analyzed using GraphPad Prism software (version 5.0, GraphPad Software Inc., San Diego, CA, USA).
+ Open protocol
+ Expand
7

Cytotoxicity Assay for Cisplatin, Olaparib, and rARL6IP5

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine 50% inhibitory concentration (IC50) values of cisplatin (cis-dichlorodiammine platinum (II); Sigma-Aldrich), olaparib (AZD2281; Adooq Bioscience, Irvine, CA, USA), and rARL6IP5, we measured the cell proliferation rate using EZ-cytox cell viability kits (DoGenBio Co., Ltd.). IC50 values were analyzed using GraphPad Prism Version 5.0 (San Diego, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!